SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-24-002826
Filing Date
2024-10-24
Accepted
2024-10-24 17:54:36
Documents
2
Period of Report
2024-10-22

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1508
2 yerxa_poa.htm EX-24 9451
  Complete submission text file 0000905148-24-002826.txt   12744
Mailing Address INSPIRE PHARMACEUTICALS, INC., 4222 EMPEROR BLVD., STE. 470 DURHAM NC 27703-8466
Business Address
YERXA BENJAMIN R (Reporting) CIK: 0001145910 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 241393661

Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Opus Genetics, Inc. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)